Kirsten Gillibrand actually said...
This is a very outside-the-box idea, but do you think there is any room or relevancy to trying to create not-for-profit drug manufacturers who do not have a profit motive so they are not focused on things such as price gouging and over-exclusivity whose goal is not just shareholder profit but perhaps well-being of patients in this country and in the world?
02/06/2018